Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Rocket Lab Stock (RKLB) Opinions on Upcoming Earnings and Neutron Progress

None

Earnings Anticipation: Social media discussions are intensifying ahead of Rocket Lab's earnings report due Thursday, with expectations for revenue around $177 million and an EPS of negative nine cents. Investors point to a robust $1.1 billion backlog skewed toward high-margin Space Systems, alongside potential boosts from heightened defense needs.

Neutron Challenges and Resilience: A recent Neutron stage one tank rupture has sparked a stock dip, yet many view it as a buying opportunity amid accelerating revenue forecasts reaching $1.5 billion by 2028. Commentary underscores the company's path to profitability in 2027 and minimal dilution risks with ample liquidity.

Defense and Launch Momentum: Buzz surrounds Rocket Lab's frequent hypersonic tests for the Pentagon and major satellite deals, cementing its status in military space tech. Long-term perspectives highlight enduring uptrends despite past corrections, fueling conviction in the space infrastructure leader.

Note: This discussion summary was generated from an AI condensation of post data.

Rocket Lab Insider Trading Activity

RKLB Insider Trades

Rocket Lab insiders have traded $RKLB stock on the open market 126 times in the past 6 months. Of those trades, 0 have been purchases and 126 have been sales.

Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

  • PETER BECK (CEO) has made 0 purchases and 25 sales selling 5,018,857 shares for an estimated $269,325,511.
  • ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 17 sales selling 2,371,134 shares for an estimated $150,985,730.
  • MATTHEW OCKO has made 0 purchases and 12 sales selling 1,873,097 shares for an estimated $90,280,094.
  • FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 21 sales selling 196,339 shares for an estimated $11,627,067.
  • MERLINE SAINTIL has made 0 purchases and 9 sales selling 143,500 shares for an estimated $11,489,000.
  • JON A OLSON has made 0 purchases and 20 sales selling 90,605 shares for an estimated $5,130,467.
  • ARJUN KAMPANI (SVP General Counsel &) has made 0 purchases and 12 sales selling 79,770 shares for an estimated $3,583,635.
  • NINA ARMAGNO has made 0 purchases and 9 sales selling 27,314 shares for an estimated $1,862,972.
  • EDWARD H. FRANK sold 2,500 shares for an estimated $193,471

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Rocket Lab Revenue

RKLB Quarterly Revenue

Rocket Lab had revenues of $155.1M in Q3 2025. This is an increase of 47.97% from the same period in the prior year.

You can track RKLB financials on Quiver Quantitative's RKLB stock page.

Rocket Lab Hedge Fund Activity

We have seen 501 institutional investors add shares of Rocket Lab stock to their portfolio, and 330 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Rocket Lab Government Contracts

We have seen $13,994,002 of award payments to $RKLB over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Rocket Lab Analyst Ratings

Wall Street analysts have issued reports on $RKLB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • B of A Securities issued a "Buy" rating on 01/20/2026
  • Morgan Stanley issued a "Overweight" rating on 01/16/2026
  • Needham issued a "Buy" rating on 12/23/2025

To track analyst ratings and price targets for Rocket Lab, check out Quiver Quantitative's $RKLB forecast page.

Rocket Lab Price Targets

Multiple analysts have issued price targets for $RKLB recently. We have seen 7 analysts offer price targets for $RKLB in the last 6 months, with a median target of $85.0.

Here are some recent targets:

  • Ronald Epstein from B of A Securities set a target price of $120.0 on 01/20/2026
  • Anthony Valentini from Goldman Sachs set a target price of $69.0 on 01/20/2026
  • Kristine Liwag from Morgan Stanley set a target price of $105.0 on 01/16/2026
  • Ryan Koontz from Needham set a target price of $90.0 on 12/23/2025
  • Erik Rasmussen from Stifel set a target price of $85.0 on 12/22/2025
  • Michael Leshock from Keybanc set a target price of $75.0 on 10/17/2025
  • Peter Arment from Baird set a target price of $83.0 on 10/16/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles